Moderna, Inc. (0QF.DE)
Develops messenger RNA vaccines and medicines for infectious diseases and cancer.
49.23+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+108.5%
The outlook
Moderna is trading near the midpoint of its 52-week range, with mixed momentum relative to its moving averages. Analyst sentiment currently leans bullish, though price action today remains flat. The stock sits in a neutral positioning rather than at an extreme in either direction.
What’s behind the score
Price trendMixed vs its moving averages
52-week range55% of the way from its 52-week low to high
Market cap
$19.53B
52-wk high
73.28
52-wk low
19.37
50-day avg
51.12
200-day avg
38.87
Trailing P/E
—